Royalty Pharma plc
Royalty Pharma plc (RPRX) Option Chain
As of September 25, 2026, Royalty Pharma plc is trading at $58.21, a -0.14% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 30.5%. IV Rank is 23%.
Read more
Tracking the RPRX option chain helps you see every strike and expiry on Royalty Pharma plc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Royalty Pharma plc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RPRX options activity at a glance. Use our scanner to monitor the RPRX option chain in real time and filter for the RPRX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RPRX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the RPRX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where RPRX stock options are being actively traded and where they are not.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes.
The company was founded in 1996 and is based in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Royalty Pharma plc's full chain across every expiry, highlights the most liquid strikes, and lets you screen RPRX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of RPRX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile16.67% Subdued
- Market cap (M$)33,474
- 52 weeks high-9.58%
- 52 weeks low68.09%
- Analyst recommendationStrong Buy
1.50 - Target price$65.71
12.88% above the current stock price - Dividend—
- Payout ratio49.40%
- Earnings date2026-11-04
- P/E30.99
- Future P/E10.15
- EPS (ttm)1.88
- EPS growth next 5 years10.23%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 7.84 | 12 | 0 | 0.44 | 5.71 | 3.80 | 8.50 | 52.50 | -9.81 | — | 3.20 | 0.00 | 3.20 | 0 | 6 | 92.16 |
| 21.89 | 569 | 9 | 0.59 | 3.21 | 3.10 | 4.50 | 55.00 | -5.51 | 0.15 | 1.55 | 0.00 | 0.85 | 0 | 19 | 78.11 |
| 43.48 | 102 | 0 | 4.19 | 0.71 | — | 4.90 | 57.50 | -1.22 | — | 2.20 | 0.00 | 2.20 | 0 | 16 | 56.52 |
| 66.32 | 204 | 0 | 0.55 | 0.00 | 0.10 | 1.00 | 60.00 | +3.08 | — | 4.50 | 1.79 | 2.71 | 0 | 13 | 33.68 |
| 83.72 | 369 | 0 | 0.75 | 0.00 | — | 0.75 | 62.50 | +7.37 | 2.00 | 6.80 | 4.29 | 0.11 | 0 | 3 | 16.28 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full RPRX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→